🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

@suyapeng, Dan Yuan, Daniel Chen & @labheath contributed to this paper published in Immunity sciencedirect.com/science/articl…

In new work published Sept. 6 in Nature Biotechnology, researchers from Fred Hutch and ISB dove deep into the metabolic changes in patients suffering from #COVID19. Jihoon William Lee Yapeng Su University of Washington Seattle MCB Program Heath Lab @Swedish go.nature.com/3tqB5ci

Longitudinal multiomics associate long-COVID sequalae with viremia, presence of autoAbs, and comorbities (T2D). Reactivation of latent viruses (#EBV) during CoV-2 and post-infection expansion of CTL implicated. Yapeng Su & Yuan & Chen Goldman/Heath labs doi.org/10.1016/j.cell…

Our longitudinal systematic investigation of 309 patients is out @cellcellpress. #LongCovid is anticipated by many factors early at diagnosis. Tour de force led by Yapeng Su, Daniel and Dan in collaboration with @swedish Providence Fred Hutch Cancer Center UW Medicine Stanford University UC San Francisco UCLA

An ISB -led study published by Cell has identified several factors that can predict if a patient is likely to develop #LongCOVID. See our story and video describing this work ⬇️ Yapeng Su Heath Lab @swedish Providence isbscience.org/news/2022/01/2…

Dr. Jim Heath's (Heath Lab) team at ISB has identified several factors that can predict if a patient is likely to develop #LongCOVID. 🩺 Read about the implications of their findings here: 📌 bit.ly/3rPkEGb

Can scientists predict a person’s risk for developing long Covid? A new study found four biological factors that could be identified early and that correlated with whether people had lingering symptoms two or three months later. nyti.ms/3FZRbhx

New research by ISB @labheath @suyapeng @swedish on #LongCovid covered in the New York Times. ⬇️🦠

New Cell An in-depth assessment of over 200 people identifies factors that may predict #LongCovid, including #SARSCoV2 level in the blood, reactivation of EB virus, autoantibodies, and #T2DM. cell.com/cell/fulltext/… @labheath ISB Yapeng Su

An important early look at factors associated with development of long COVID. Thanks #HAARVI participants for your role. It was a pleasure to collaborate with @labheath, Jason Goldman, and ISB on this work.

Now online! Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae dlvr.it/SHr0nW

Excited to share our #LongCovid #COVID-19 paper Cell. cell.com/cell/fulltext/…

Check out our #LongCOVID Cell paper ISB covered @NYTimes by Pam Belluck with insightful discussion from Drs. Steven Deeks, Avindra Nath, and Prof. Akiko Iwasaki.

What predicts long-COVID? Study led by Seattle researchers at ISB provides some answers. Thank you to Heath Lab for the interview. geekwire.com/2022/what-pred… via @GeekWire

The #LongCovid research by @labheath, Yapeng Su and many others was covered in this piece by Sumathi Reddy of The Wall Street Journal. @swedish Providence Fred Hutch Cancer Center Cell

Our recent research on #LongCovid continues to make headlines. Check out this article from Emily Sohn, National Geographic nationalgeographic.com/science/articl… Yapeng Su, Heath Lab, Fred Hutch Cancer Center, Jason Goldman

As part of a nationwide effort to understand #LongCovid, ISB is leading a multi-site Pacific Northwest consortium as part of the NIH-funded RECOVER initiative. @Swedish Providence UW Medicine Heath Lab isbscience.org/news/2022/03/0…

Researchers will recruit 900 patients for new clinical study on long-COVID, led by Heath Lab at ISB. Other investigators include Helen Chu UW Medicine and Dr. Jason Goldman at @Swedish geekwire.com/2022/understan… via @GeekWire

Incredible new Cell cover featuring the work to understand early predictors of long COVID, studies led by ISB Heath Lab Jason Goldman @Swedish, in collaboration with our #HAARVI research team @uwmedicine Denise McCulloch Jenni Logue Nicholas Franko

Check out the new Cell cover featuring our study on early risk factors of long COVID, led by Yapeng Su, Dan and Daniel, in collaboration with Jason Goldman @Swedish, Helen Chu @uwmedicine, and many amazing scientists from Stanford Medicine Fred Hutch Cancer Center UC San Francisco UCLA etc.